Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 10.82% is 600% above its 5-year average of -2.16%, near the high end of its 5-year range (-39.61%–13.25%).
13.96% above its 12-month average of 9.49%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 9.29%.
NET PROFIT MARGIN
10.82%
NET PROFIT MARGIN AVG TTM
9.49%
NET PROFIT MARGIN AVG 3Y
6.28%
NET PROFIT MARGIN AVG 5Y
-2.16%
NET PROFIT MARGIN AVG 10Y
-1.06%
NET PROFIT MARGIN AVG 15Y
1.67%
NET PROFIT MARGIN AVG 20Y
-118.48%
CURRENT VS TTM AVG
+13.96%
CURRENT VS 3Y AVG
+72.19%
CURRENT VS 5Y AVG
+599.98%
CURRENT VS 10Y AVG
+1119.23%
CURRENT VS 15Y AVG
+546.74%
CURRENT VS 20Y AVG
+109.13%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 511 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
ANI Pharmaceuticals, Inc.
Market Cap
$1.66B
Net Profit Margin
10.82%
TTM Avg
9.49%
3Y Avg
6.28%
5Y Avg
-2.16%
Market Cap
$1.66B
Net Profit Margin
-13.50%
TTM Avg
-22.64%
3Y Avg
-31.77%
5Y Avg
-40.07%
Market Cap
$1.68B
Net Profit Margin
-140.43%
TTM Avg
-164.31%
3Y Avg
-442.76%
5Y Avg
-354.21%
Market Cap
$1.71B
Net Profit Margin
-14.99%
TTM Avg
-20.12%
3Y Avg
-16.95%
5Y Avg
-10.04%
Market Cap
$1.74B
Net Profit Margin
-672.16%
TTM Avg
-753.31%
3Y Avg
-935.73%
5Y Avg
-797.48%
Market Cap
$1.75B
Net Profit Margin
0.89%
TTM Avg
-2.38%
3Y Avg
-5.83%
5Y Avg
-7.07%
Market Cap
$1.56B
Net Profit Margin
-16.75%
TTM Avg
-1.75%
3Y Avg
-3.69%
5Y Avg
-6.61%
Market Cap
$1.54B
Net Profit Margin
80.56%
TTM Avg
35.15%
3Y Avg
48.19%
5Y Avg
54.54%
Market Cap
$1.53B
Net Profit Margin
12.02%
TTM Avg
-7.78%
3Y Avg
-15.24%
5Y Avg
-11964.64%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ANI Pharmaceuticals, Inc. (ANIP) | $1.66B | 10.82% | 9.49% | 6.28% | -2.16% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.66B | -13.50% | -22.64% | -31.77% | -40.07% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.68B | -140.43% | -164.31% | -442.76% | -354.21% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | -14.99% | -20.12% | -16.95% | -10.04% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.74B | -672.16% | -753.31% | -935.73% | -797.48% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.75B | 0.89% | -2.38% | -5.83% | -7.07% |
| Certara, Inc. (CERT)vs › | $1.56B | -16.75% | -1.75% | -3.69% | -6.61% |
| Innoviva, Inc. (INVA)vs › | $1.54B | 80.56% | 35.15% | 48.19% | 54.54% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.53B | 12.02% | -7.78% | -15.24% | -11964.64% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.53B | N/A | N/A | N/A | N/A |
Operating Margin
15.3%
Net Profit Margin
10.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 9.29% |
| 2026-03-31 | 12.42% |
| 2025-12-31 | 11.13% |
| 2025-09-30 | 10.59% |
| 2025-06-30 | 4.04% |
| 2025-03-31 | 7.95% |
| 2024-12-31 | -5.39% |
| 2024-09-30 | -16.29% |
| 2024-06-30 | -1.66% |
| 2024-03-31 | 13.25% |
| 2023-12-31 | 0.88% |
| 2023-09-30 | 7.54% |
| 2023-06-30 | 5.36% |
| 2023-03-31 | 1.35% |
| 2022-12-31 | -4.50% |
| 2022-09-30 | -10.26% |
| 2022-06-30 | -20.21% |
| 2022-03-31 | -31.22% |
| 2021-12-31 | -39.61% |
| 2021-09-30 | -8.54% |
| 2021-06-30 | -29.01% |
| 2021-03-31 | 0.16% |
| 2020-12-31 | -6.35% |
| 2020-09-30 | 0.82% |
| 2020-06-30 | -25.45% |
| 2020-03-31 | -14.09% |
| 2019-12-31 | -10.08% |
| 2019-09-30 | 7.46% |
| 2019-06-30 | 11.92% |
| 2019-03-31 | 0.83% |
| 2018-12-31 | 9.41% |
| 2018-09-30 | 9.83% |
| 2018-06-30 | 5.82% |
| 2018-03-31 | 4.81% |
| 2017-12-31 | -20.36% |
| 2017-09-30 | 9.73% |
| 2017-06-30 | 5.94% |
| 2017-03-31 | 3.12% |
| 2016-12-31 | -2.83% |
| 2016-09-30 | 6.56% |
| 2016-06-30 | 3.56% |
| 2016-03-31 | 6.51% |
| 2015-12-31 | 15.93% |
| 2015-09-30 | 22.68% |
| 2015-06-30 | 18.17% |
| 2015-03-31 | 23.12% |
| 2014-12-31 | 99.55% |
| 2014-09-30 | 38.31% |
| 2014-06-30 | -35.55% |
| 2014-03-31 | 30.68% |
| 2013-12-31 | 32.59% |
| 2013-09-30 | 14.96% |
| 2013-06-30 | -74.51% |
| 2013-03-31 | -1579.32% |
| 2012-12-31 | -202.65% |
| 2012-09-30 | -5545.98% |
| 2012-06-30 | -6751.35% |
| 2012-03-31 | -9003.93% |
| 2011-12-31 | -5813.35% |
| 2011-09-30 | -6966.52% |
| 2011-06-30 | -18487.25% |
| 2011-03-31 | -30264.34% |
| 2010-12-31 | -9278.86% |
| 2010-09-30 | -22578.39% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | -462.32% |
| 2009-12-31 | -3053.27% |
| 2009-09-30 | -60718.22% |
| 2009-06-30 | -4012.31% |
| 2009-03-31 | -5919.52% |
| 2008-12-31 | -32.28% |
| 2008-09-30 | -8009.88% |
| 2008-06-30 | -23379.59% |
| 2008-03-31 | -7953.68% |
| 2007-12-31 | -508.51% |
| 2007-09-30 | -3866.02% |
| 2007-06-30 | -3456.37% |
| 2007-03-31 | -3590.38% |
| 2006-12-31 | 64.04% |
| 2006-09-30 | -530.96% |
| 2006-06-30 | -1269.55% |
| 2006-03-31 | -3812.63% |
| 2005-12-31 | -2522.14% |
| 2005-09-30 | -2127.54% |
| 2005-06-30 | -5661.87% |
| 2005-03-31 | -9661.03% |
| 2004-12-31 | -7526.96% |
| 2004-09-30 | -26664.51% |
| 2004-06-30 | -51731.47% |
| 2004-03-31 | -33423.06% |
| 2003-12-31 | 2979.23% |
| 2003-09-30 | -5665.20% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | -1476.26% |
| 2002-12-31 | -22.34% |
| 2002-09-30 | -83.22% |
